Long-term outcomes after TAVI

Chairpersons: R. Kornowski, H. Moellmann
React@PCR Moderator: S. Cannata

Learning Objectives

  • To fully understand the mechanisms of transcatheter valve failure and comparisons with surgical bioprostheses
  • To know more about current thinking concerning the phenomenon of TAVI leaflet thickening and subclinical thrombosis
  • To identify ways in which TAVI may emerge as long-term treatment strategy in younger, low-risk patients

Presentations available when logged in:

  • Session objectives
  • How and why might transcatheter valves fail?
  • TAVI durability and comparisons with surgery
  • TAVI leaflet thickening and subclinical thrombosis: keep calm and carry on imaging
  • Infective endocarditis following TAVI - incidence and outcomes
  • TAV in TAV – current reality and future feasibility
  • Session evaluation and key learnings